Schrodinger's mouse: human observation erases a drug-induced behavioral phenotype
Krausz, T. A.; Roseberry, T. K.; Williams, G.; Tingley, D.
Show abstract
Animal studies primarily rely on human monitoring for health and behavioral outcomes. The presence of a human, however, can induce stress and potentially alter experimental results. We sought to answer whether human observation alone is enough to change experimental outcomes and obscure the effect of interest. Our automated home-cage behavioral phenotyping system provided the ideal platform to test this hypothesis. Two cohorts received semaglutide (0.03 mg/kg, intraperitoneally) on separate consecutive days. The first cohort was recorded without inspection after dosing; the second underwent a brief visual health check with no handling. Recordings from the checked cohort on the preceding day, without injection or inspection, provided a matched baseline. A single brief check produced large, time-locked changes across the behavioral repertoire. The changes began before the cage door was opened, indicating a response to experimenter proximity. In addition to adding variance, the semaglutide-treated animals' behavior during observation was more similar to the no-injection baseline than to the semaglutide/no-check reference, transiently erasing the drug phenotype. Brief human observation is therefore not a neutral measurement operation; over the minutes surrounding it, it is a perturbation in itself that is large enough to mask the drug effect it is meant to record.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacological prevention of neonatal opioid withdrawal in a pregnant guinea pig model. 92%
- Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing 91%
- Near, far, wherever you are: Phenotype-related variation in pharmacogenomic effect sizes across the psychiatric drug literature. 91%
Similar papers in this journal
- A genetic model of ivabradine recapitulates results from randomized clinical trials 92%
- Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians 91%
- Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking 91%
Similar papers in this journal
- Therapeutic doses of ketamine acutely attenuate the aversive effect of losses during decision-making. 92%
- A preclinical model of THC edibles that produces high-dose cannabimimetic responses. 91%
- NBI-921352, a First-in-Class, Na V 1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of- Function Mice, and Wild-Type Mice and Rats 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.